Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc. (TERN) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 104 transactions totaling $102.9M, demonstrating a bullish sentiment with $76.6M in net insider flow. The most recent transaction on Feb 1, 2026 involved a transaction of 2,828 shares valued at $0.
TERN Insider Activity Summary
Who Is Buying TERN Stock?
No significant insider buying has been recorded for TERN in the recent period.
Who Is Selling TERN Stock?
No significant insider selling has been recorded for TERN in the recent period.
Is Terns Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TERN is bullish with an Insider Alignment Score of 87/100 and a net flow of $76.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TERN Frequently Asked Questions
Understanding TERN Insider Activity
Insider trading at Terns Pharmaceuticals, Inc. (TERN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading TERN stock, having executed 104 transactions in the past 90 days. The most active insider is Hongbo Lu (Executive), who has made 7 transactions totaling $19.6M.
Related Tools
Track Terns Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at TERN file new Form 4 transactions